"This isn't a missing hormone - it's a receptor nobody thought to activate."
Cravings that won't let up. Appetite that feels impossible to manage. Weight that won't move no matter what you try. For most people, the first explanation offered is a missing hormone, and the first response is an injection. But what if the hormone isn't missing at all? What if your body can still make it, and no one's engaged the switch? In this episode of The Resiliency Method® The Truth About Healing Podcast, Dr. Erika Schultz sits down with Joe Virzi, RN and Account Executive for Orthomolecular Products, to ask a question most GLP-1 conversations skip: what if the drug isn't replacing a missing function, but bypassing one your body already has?
A Discovery Backed by $20 Million and 300 Biopsies
Joe and Dr. Erika open with the origin of Calocurb's key ingredient, amarasate, a hops extract from New Zealand. A local research team, backed by a $20 million government grant, set out to test whether bitter taste receptors (TAS2R) exist beyond the tongue. Through roughly 300 biopsies taken during colonoscopies, they confirmed these receptors run throughout the GI tract, most densely near the terminal ileum - territory a standard workup never checks.
Support the System, Don't Replace It
This is the episode's clinical reframe. Dr. Erika draws a parallel to how NAC supports the body's own glutathione production rather than replacing it directly. Calocurb works the same way: activating TAS2R receptors triggers the body's own production of GLP-1, CCK, and PYY, instead of introducing those hormones from outside.
"Supporting the body's own production isn't slower medicine - it's medicine that holds."
What the Numbers Show
Three completed human trials found a roughly 600% increase in satiety hormones and an 18% reduction in caloric intake. A fourth study, published this month in Obesity Pillars, tracked outcomes over six months and found reductions in body weight, body fat, and visceral fat, with muscle mass preserved a notable contrast to the muscle loss often seen with injectable GLP-1 drugs.
How It Compares to Injectables
Calocurb is taken orally, costs roughly a third of injectable GLP-1 medications, and uses a single active ingredient with a milder side effect profile. It isn't positioned to replace every patient's protocol, but for those exploring alternatives to injections or peptide therapy, it's worth understanding.
A Different Way to Approach Weight Loss
This episode is a reminder that supporting metabolic health doesn't have to mean bypassing what your body can already do. When the right receptors are engaged, appetite regulation stops being something done to the body and starts being something restored within it.
Ready to Learn More About Supporting Your Body's Own GLP-1 Production? Explore here: https://www.drerikaonline.com/discovery
And For Direct Order: https://paramountwell.com/products/calocurb%C2%AE-clinical-starter-pack
Listen here:
